hyfc EPO (long acting)

hyfc EPO (long acting)
Product Description

Efesa, is a long-acting Erythropoietin indicated for CKD-induced anemia in dialysis and non-dialysis patients. Efesa is a hybrid Fc of IgG4 and IgD that provides hinge flexibility and long serum half-life without causing toxicity to target cells. Global Phase 3 trial for non-dialysis indication is currently still ongoing and CSR is expected to be completed in Q3 2023. Interim results showed that Efesa has a non-inferior efficacy compared to Mircera without serious safety issues.

Read more Show less

Kalbe

  • Country/Region:
    Indonesia
  • On CPHI since:
    2018
  • Certificates:
    3
  • Employees:
    5000+
Company types
Contract Service
Distributor/Import Export
Licensee
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Contract Manufacturer
Finished Formulation products Distributor/Buyer
Ingredients Distributor/Buyer
Natural Extracts
Out-licensing specialist
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Product Features; Product Performance
More specifications Fewer specifications
Sales Markets
Show more Show less

Kalbe

  • Country/Region:
    Indonesia
  • On CPHI since:
    2018
  • Certificates:
    3
  • Employees:
    5000+
Company types
Contract Service
Distributor/Import Export
Licensee
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Contract Manufacturer
Finished Formulation products Distributor/Buyer
Ingredients Distributor/Buyer
Natural Extracts
Out-licensing specialist
Pharmaceutical Company (generic finished products)
View company profile

More Products from Kalbe (2)

  • Nimotuzumab

    Product Nimotuzumab

    Nimotuzumab binds with intermediate affinity and high specificity to the extracellular domain of EGFR and blocks the binding of the EGF to its receptor and inhibits tumor cell growth. The molecule induces cell lysis through ADCC mechanism. Nimotuzumab provides vaccinal effect that induce memory T-cell ...
  • Insulin Glargine

    Product Insulin Glargine

    Long-acting basal insulin analogue to treat Type I and II Diabetes Mellitus.

Kalbe resources (1)